ANI Pharmaceuticals Inc. (NASDAQ: ANIP) stock closed at 35.39 per share at the end of the most recent trading day (a 1.2% change compared to the prior day closing price) with a volume of 96.28K shares and market capitalization of 616.71M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 338 people. ANI Pharmaceuticals Inc. CEO is Nikhil Lalwani.

The one-year performance of ANI Pharmaceuticals Inc. stock is 14.62%, while year-to-date (YTD) performance is -23.2%. ANIP stock has a five-year performance of -19.59%. Its 52-week range is between 22.31 and 60.2267, which gives ANIP stock a 52-week price range ratio of 34.50%

ANI Pharmaceuticals Inc. currently has a PE ratio of -6.70, a price-to-book (PB) ratio of 1.68, a price-to-sale (PS) ratio of 3.01, a price to cashflow ratio of 100.40, a PEG ratio of 2.32, a ROA of -10.72%, a ROC of -10.27% and a ROE of -24.69%. The company’s profit margin is -27.17%, its EBITDA margin is -6.70%, and its revenue ttm is $177.47 Million , which makes it $10.30 revenue per share.

Of the last four earnings reports from ANI Pharmaceuticals Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.04 for the next earnings report. ANI Pharmaceuticals Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for ANI Pharmaceuticals Inc. is Moderate Buy (2), with a target price of $40.67, which is +14.92% compared to the current price. The earnings rating for ANI Pharmaceuticals Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ANI Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ANI Pharmaceuticals Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 5.55, ATR14 : 1.63, CCI20 : 109.33, Chaikin Money Flow : 0.08, MACD : 1.29, Money Flow Index : 66.29, ROC : 5.80, RSI : 68.22, STOCH (14,3) : 56.03, STOCH RSI : 0.83, UO : 52.01, Williams %R : -43.97), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ANI Pharmaceuticals Inc. in the last 12-months were: Antonio R. Pera (Buy at a value of $126 794), Chad Gassert (Buy at a value of $275 087), Jeanne Thoma (Buy at a value of $49 820), Muthusamy Shanmugam (Buy at a value of $138 252), Nikhil Lalwani (Buy at a value of $199 997), Patrick D. Walsh (Buy at a value of $138 794)